The 2021 approval by regulatory agencies of belimumab, a B lymphocyte stimulator (BLyS) inhibitor, and the 2022 approval of anifrolumab, a type I interferon inhibitor, has increased the therapeutic ...
9 Over a median 14.3 months, the 71% ORR endured with 200 mg and more patients (50%) achieved a CR or better. Stringent CR, ...
b During this visit, the patient was prescribed prednisone 10 mg orally daily and his warfarin dosage was decreased to 9 mg weekly. c During this visit, the patient’s warfarin dosage was ...
Advice for first-time home buyers from Money Box Live.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback